Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.1%

1 terminated/withdrawn out of 32 trials

Success Rate

94.7%

+8.2% vs industry average

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

17%

3 of 18 completed trials have results

Key Signals

4 recruiting3 with results

Enrollment Performance

Analytics

N/A
16(66.7%)
Phase 1
3(12.5%)
Phase 3
3(12.5%)
Early Phase 1
1(4.2%)
Phase 2
1(4.2%)
24Total
N/A(16)
Phase 1(3)
Phase 3(3)
Early Phase 1(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (32)

Showing 20 of 32 trials
NCT04307576Phase 3Recruiting

A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Role: collaborator

NCT07502820Phase 3Not Yet Recruiting

The POWER Trial: Personalised Dose Optimisation With Adjuvant Tamoxifen Therapy in Breast cancER

Role: collaborator

NCT07173270Not ApplicableNot Yet Recruiting

Improved Oral Health in Head and Neck Cancer Survivors

Role: collaborator

NCT06307418Not ApplicableRecruiting

Internet-based Support for Informal Caregivers of Patients With Head and Neck Cancer - Carer eSupport

Role: collaborator

NCT06883604Not ApplicableRecruiting

Clinical Investigation of Proton Treatment in Hodgkin Lymphoma Patients - PRO-Hodgkin

Role: collaborator

NCT06446401Recruiting

The Case of "Triple" Versus "Double" Therapy for Patients With High Volume Metastatic Hormone Sensitive Prostate Cancer

Role: collaborator

NCT03343236Active Not Recruiting

Nutrition and Inflammation in Patients with Head and Neck Cancer

Role: collaborator

NCT05064670Not ApplicableCompleted

Exercise as Medicine for People With Cancer Sweden

Role: collaborator

NCT05028452Not ApplicableCompleted

Feasibility of Internet Based Support (Carer eSupport) for Informal Caregivers of Patients With Head and Neck Cancer

Role: collaborator

NCT02473003Not ApplicableUnknown

Physical Training and Cancer-a Multicenter Clinical Trial

Role: collaborator

NCT03729687Phase 2Unknown

Short Course Radiation Therapy Followed by Pre-operative Chemotherapy and Surgery in High-risk Rectal Cancer

Role: collaborator

NCT01216202Completed

Sexual Function and Wellbeing in Males With Rectal Cancer

Role: collaborator

NCT05729451Completed

Change in Cardiorespiratory Fitness and Breast Cancer Incidence and Mortality

Role: collaborator

NCT04586517Not ApplicableUnknown

Effect of Heavy-load Resistance Training During Chemotherapy on Muscle Cellular Outcomes

Role: collaborator

NCT05339230Not ApplicableUnknown

Role of Antisecretory Factor in Dihydropyrimidine Treatment of Colorectal Cancer

Role: collaborator

NCT05351931Not ApplicableUnknown

Role of Antisecretory Factor in Curative Radiochemotherapy for Anal Carcinoma

Role: collaborator

NCT03655353Not ApplicableUnknown

A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer

Role: collaborator

NCT00904813Not ApplicableCompleted

The Stockholm III Trial on Different Preoperative Radiotherapy Regimens in Rectal Cancer

Role: collaborator

NCT01216189Completed

Sexual Function and Wellbeing in Females With Rectal Cancer

Role: collaborator

NCT04461457Early Phase 1Completed

Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2

Role: collaborator